I have been looking at THLD, spec that had success in 2005 and stock shot up to 100pps but compound was causing liver damage. Have new compound in 1/2 trials seems very interesting. Bought very small position may be good gamble. Have any thoughts??
This is not a pump, I own MNTA and like the opinions on this board.
looks very very very early on for that compound. I tend to stay away from companies that talk about the results in 1 patient, or a trial of 6 patients per arm. Too risky for me, but thanks for sharing the idea.
Still think this will go up much higher, in last two days up about 140%. We all know the drug works it's whether they were able to overcome the side effect that hurt them in their last try when the stock shot up to 100pps.